NINDS Offers IGNITE Grants for Neurotherapeutic Agent Characterization and In Vivo Efficacy Studies
SynopsisVersion HistoryRelated DocumentsPackage This grant, offered by the National Institute of Neurological Disorders and Stroke (NINDS) as part of its IGNITE program, is for funding studies to characterize neurotherapeutic agents. Specifically, it supports pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to prove that proposed therapeutic agents, including small molecules, biologics, or biotechnology-derived products, possess sufficient biological activity. The ultimate goal is to advance these agents to a stage suitable for further [...]